👴Anti-Aging & Longevity

An investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, producing unprecedented weight loss of up to 24% in clinical trials.

A modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and inhibits lipogenesis without the diabetogenic or growth-promoting effects of full-length HGH.

An investigational dual glucagon and GLP-1 receptor agonist being developed for obesity and MASH (metabolic dysfunction-associated steatohepatitis) with significant liver fat reduction.

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and obesity management, with cardiovascular and neuroprotective benefits.

A naturally occurring copper-binding tripeptide that declines with age, known for potent wound healing, collagen stimulation, anti-aging skin effects, and hair growth promotion.

The first 29 amino acids of natural GHRH, previously FDA-approved for pediatric GH deficiency. Now widely used off-label for anti-aging GH optimization as a safer alternative to direct HGH therapy.

An FDA-approved synthetic analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification, indicated for HIV-associated lipodystrophy and studied for cognitive benefits and visceral fat reduction.

A long-acting growth hormone-releasing hormone (GHRH) analog with a Drug Affinity Complex that extends its half-life to 6-8 days, producing sustained elevated growth hormone and IGF-1 levels.

A thymic peptide bioregulator developed in Russia that restores immune function by promoting T-cell maturation and has shown anti-aging effects in clinical studies on elderly patients.

A highly selective growth hormone-releasing peptide (GHRP) that stimulates GH release with minimal impact on cortisol, prolactin, or appetite, making it the cleanest GHRP available.

An orally active, non-peptide growth hormone secretagogue that mimics ghrelin to raise GH and IGF-1 levels for up to 24 hours per dose, with notable effects on sleep, appetite, and body composition.

A modified growth hormone-releasing hormone fragment with a short half-life (~30 minutes) that stimulates pulsatile growth hormone release, closely mimicking the body's natural GH secretion pattern.

A synthetic cyclic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) that induces skin tanning, increases libido, and reduces appetite through melanocortin receptor activation.

An FDA-approved once-weekly GLP-1 receptor agonist for type 2 diabetes with proven cardiovascular benefits and convenient single-use pen delivery.

The first GLP-1 receptor agonist approved for type 2 diabetes, originally derived from Gila monster venom, available in twice-daily and once-weekly formulations.

An oligopeptide derived from angiotensin IV that is reported to be 10 million times more potent than BDNF at enhancing cognitive function through hepatocyte growth factor (HGF) signaling.

A porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids, used clinically in many countries for stroke recovery, traumatic brain injury, and dementia.

A small synthetic peptide derived from ciliary neurotrophic factor (CNTF) that promotes neurogenesis and enhances cognitive function by inhibiting leukemia inhibitory factor (LIF) signaling.

A zinc-dependent nonapeptide hormone produced by thymic epithelial cells that plays an essential role in T-cell differentiation and immune regulation, declining significantly with age.

A small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that promotes fat loss by increasing NAD+ levels and cellular energy metabolism, available as an oral compound.

A lipopeptide used in cosmetic skincare that stimulates collagen and extracellular matrix production, often marketed as a non-invasive alternative to retinol for anti-wrinkle treatment.

A synthetic hexapeptide that inhibits neurotransmitter release at the neuromuscular junction, reducing facial muscle contraction and wrinkle formation — often called 'Botox in a bottle'.

A synthetic analog of alpha-melanocyte stimulating hormone (α-MSH) that stimulates melanin production for photoprotection, FDA-approved (as Scenesse) for erythropoietic protoporphyria (EPP).

A semi-synthetic polysaccharide (heparin-like compound) used clinically for interstitial cystitis and osteoarthritis, with disease-modifying effects on cartilage, joints, and the glycosaminoglycan layer.